 | |
| Clinical data | |
|---|---|
| AHFS/ Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard ( EPA) | |
| ECHA InfoCard | 100.044.084 |
| Chemical and physical data | |
| Formula | C18H14Cl4N2O |
| Molar mass | 416.12 g·mol−1 |
| 3D model ( JSmol) | |
| |
Isoconazole is an azole antifungal drug and could inhibit gram positive bacteria. [1] [2] For foot and vaginal infections, isoconazole has a similar effectiveness to clotrimazole. [3] [4] Isoconazole nitrate may be used in combination with corticosteroid diflucortolone to increase its bioavailability. [1]
It was patented in 1968 and approved for medical use in 1979. [5]
References
- ^ a b Veraldi S (May 2013). "Isoconazole nitrate: a unique broad-spectrum antimicrobial azole effective in the treatment of dermatomycoses, both as monotherapy and in combination with corticosteroids". Mycoses. 56 (Suppl 1): 3–15. doi: 10.1111/myc.12054. PMID 23574019. S2CID 1881151.
- ^ Budavari S, O'Neil M, Smith A, Heckelman P, Obenchain J (1996). "Isoconazole". In Budavari S (ed.). The Merck Index (12th ed.). p. 5176. ISBN 0-911910-12-3.
- ^ Oyeka CA, Gugnani HC (1992). "Isoconazole nitrate versus clotrimazole in foot and nail infections due to Hendersonula toruloidea, Scytalidium hyalinum and dermatophytes". Mycoses. 35 (11–12): 357–361. doi: 10.1111/j.1439-0507.1992.tb00894.x. PMID 1302811. S2CID 6764090.
- ^ Cohen L (February 1984). "Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole". The British Journal of Venereal Diseases. 60 (1): 42–44. doi: 10.1136/sti.60.1.42. PMC 1046268. PMID 6365236.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 502. ISBN 9783527607495.
 | This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |